Stay updated with breaking news from Product Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration (FDA) has rejected Elon Musk's application to conduct human trials of his Neuralink brain implant device over safety concerns. Seven current and former [...]
On at least four occasions since 2019, Elon Musk has predicted that his medical device company, Neuralink, would soon start human trials of a revolutionary brain implant to treat intractable conditions such as paralysis and blindness. Yet the company, founded in 2016, didn't seek permission from the US Food and Drug Administration (FDA) until early 2022 — and the agency...
BRAIN initiative team leader Nick Langhals said the agency reached out to Neuralink to offer help but was declined.
A year after the rejection, Neuralink is still working through the agency's concerns
The Global Fund invites manufacturers of pharmaceutical products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for pharmaceutical products (ERP).